These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15488360)

  • 1. Physical inactivity: direct cost to a health plan.
    Garrett NA; Brasure M; Schmitz KH; Schultz MM; Huber MR
    Am J Prev Med; 2004 Nov; 27(4):304-9. PubMed ID: 15488360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported health risks linked to health plan cost and age group.
    Hill RK; Thompson JW; Shaw JL; Pinidiya SD; Card-Higginson P
    Am J Prev Med; 2009 Jun; 36(6):468-74. PubMed ID: 19460654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monthly estimates of leisure-time physical inactivity--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 May; 46(18):393-7. PubMed ID: 9157273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes complications and depression as predictors of health service costs.
    Simon GE; Katon WJ; Lin EH; Ludman E; VonKorff M; Ciechanowski P; Young BA
    Gen Hosp Psychiatry; 2005; 27(5):344-51. PubMed ID: 16168795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic cost of physical inactivity in China.
    Zhang J; Chaaban J
    Prev Med; 2013 Jan; 56(1):75-8. PubMed ID: 23200874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease.
    Oldridge NB
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):130-9. PubMed ID: 18391637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting physical activity: a profile of health plan programs and initiatives.
    Fitzner K; Madison M; Caputo N; Brown E; French M; Bondi M; Jennings C
    Manag Care Interface; 2002 Dec; 15(12):29-41. PubMed ID: 12530293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.